{"id":"m1-c6v1","_chembl":{"chemblId":"CHEMBL1236670","moleculeType":"Small molecule","molecularWeight":"525.60"},"_dailymed":null,"_scrapedAt":"2026-03-28T04:31:42.024Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T09:38:34.005682+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT06046742","phase":"PHASE1","title":"A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Guangzhou Virotech Pharmaceutical Co., Ltd.","startDate":"2024-07-10","conditions":"Solid Tumor","enrollment":12},{"nctId":"NCT04665362","phase":"PHASE1","title":"IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC","status":"UNKNOWN","sponsor":"Liang Peng","startDate":"2021-01-25","conditions":"Advanced/Metastatic Hepatocellular Carcinoma","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"M1-c6v1","genericName":"M1-c6v1","companyName":"Guangzhou Virotech Pharmaceutical Co., Ltd.","companyId":"guangzhou-virotech-pharmaceutical-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T09:38:34.005682+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}